The India tumor ablation market size reached USD 72.30 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 243.30 Million by 2033, exhibiting a growth rate (CAGR) of 12.90% during 2025-2033. The India tumor ablation market share is influenced by rising cancer prevalence, increasing demand for minimally invasive tumor ablation treatments, and technological advancements like artificial intelligence (AI) and real-time imaging. Besides this, growing preference for non-surgical procedures ensures shorter recovery times, fewer complications, and improved treatment outcomes, strengthening market expansion.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024 |
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 72.30 Million |
Market Forecast in 2033 | USD 243.30 Million |
Market Growth Rate 2025-2033 | 12.90% |
Growing Technological Advancements
Innovations in radiofrequency, microwave, and cryoablation techniques are enhancing efficiency and reducing procedural complications in tumor treatment. These advanced technologies enable accurate tumor targeting, reducing harm to adjacent healthy tissues during ablation procedures. The integration of real-time imaging including ultrasound, computerized tomography (CT), and magnetic resonance imaging (MRI), is significantly improving accuracy and treatment outcomes. Robotics and AI are further refining precision, ensuring higher success rates in tumor ablation therapies across India. Minimally invasive ablation techniques are gaining momentum due to shorter recovery times and reduced hospital stays. The development of portable and user-friendly ablation devices is expanding accessibility in smaller healthcare centers. Increasing research and development (R&D) in nanotechnology is driving more effective heat-based tumor destruction with minimal side effects. Advancements in catheter-based ablation techniques allow for the treatment of deep-seated tumors with greater accuracy. Improved cooling mechanisms in cryoablation are enhancing safety and reducing complications during tumor removal. The availability of next-generation ablation systems is ensuring better outcomes for cancer patients. For example, in September 2024, Ankura Hospital, in collaboration with IMAA and Nuvarium Medical Academy, hosted India’s first Gynecologic Microwave Ablation (MWA) Workshop, training specialists in minimally invasive MWA techniques. This initiative promoted non-surgical tumor treatments, strengthening gynecologic care, and further fueling the India tumor ablation market growth.
Rising Cancer Prevalence
The rising incidence of lung, liver, kidney, and bone tumors is significantly influencing the India tumor ablation market outlook. This minimally invasive technique is becoming a preferred option due to its effectiveness in cancer treatment. Increasing cancer cases, expected to rise from 1.46 million in 2022 to 1.57 million by 2025 (NIH), are leading to greater patient awareness about treatment alternatives. Tumor ablation offers a targeted solution, minimizing damage to surrounding healthy tissues during cancer treatment. The surge in cancer-related mortality is encouraging healthcare providers to adopt advanced ablation technologies for better outcomes. Moreover, urbanization and lifestyle changes are contributing to a sharp increase in cancer cases across various demographics. Factors like smoking, alcohol consumption, pollution, and unhealthy diets are elevating cancer risks, necessitating improved treatment options. The growing geriatric population, which is more vulnerable to cancer, is further driving the demand for tumor ablation therapies. Early cancer detection through enhanced screening programs is leading to more tumor ablation procedures across India. Government initiatives promoting cancer awareness and affordable treatments are playing a crucial role in market growth. Increasing healthcare investments are improving infrastructure, ensuring better access to advanced ablation therapies. Collaborations between hospitals and technology providers are enhancing treatment efficacy, accelerating market expansion.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the regional level for 2025-2033. Our report has categorized the market based on technology, treatment, and application.
Technology Insights:
The report has provided a detailed breakup and analysis of the market based on the technology. This includes radiofrequency ablation, microwave ablation, HIFU, irreversible electroporation ablation, cryoablation, and others.
Treatment Insights:
A detailed breakup and analysis of the market based on the treatment have also been provided in the report. This includes surgical ablation, laparoscopic ablation, and percutaneous ablation.
Application Insights:
The report has provided a detailed breakup and analysis of the market based on the application. This includes kidney cancer, liver cancer, breast cancer, lung cancer, prostate cancer, and others.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include North India, South India, East India, and West India.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Technologies Covered | Radiofrequency Ablation, Microwave Ablation, HIFU, Irreversible Electroporation Ablation, Cryoablation, Others |
Treatments Covered | Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation |
Applications Covered | Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Others |
Regions Covered | North India, South India, East India, West India |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
Key Benefits for Stakeholders: